A woman looking ahead with a vision of a couple hiking in her head

Home
Biopharma partnerships

Biopharma partnerships

NeoGenomics offers unparalleled services to accelerate your complex drug development program and clinical trials, supported by a network
of College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified laboratories.

Pharma Services Client Portal

hero anchor

Where trust meets results - 300+ biopharma partners

At NeoGenomics, we understand the needs of pharmaceutical and biotechnology companies, and we align with our partners to support development of therapies that will save lives. With over a decade of experience, we are a trusted partner in oncology research and development, delivering solutions to advance your drug development and clinical trial programs for targeted therapies and emerging treatment modalities.

No matter the scale or business need, we deliver:

Seamless end-to-end multimodal testing services, eliminating the need for multiple vendors
Broad biopharmaceutical test menu and integrated data analysis
Advanced customized solutions to accelerate your development program
Deep scientific and technical expertise with MDs, PhDs, and dedicated project managers ensuring project integrity

In-house regulatory and compliance team to effectively navigate complex regulatory processes and support submissions
Certified pathology staff capable of performing US FDA-approved companion diagnostic confirmations
Large-scale, real-world oncology data to better inform clinical trials

Lab services

Cell therapy solutions

Antibody-drug conjugates (ADCs) solutions

Biomarker solutions

Lab services

Comprehensive lab service offerings

Whether you need a standard off-the-shelf assay from our robust testing menu or prefer to have tailored solutions, we can help. Our regulatory, quality, and operational expertise ensures that you can fast-track your critical milestones.

Move your drug development and clinical trials forward, faster.

Cell therapy solutions

Fast-track your cell therapy program and clinical trials breakthroughs

We understand the need of pharmaceutical and biotechnology companies to harness the power of cell therapies in the fight against cancer. Our comprehensive suite of cell therapy multi-modality testing solutions leverage over a decade of experience, including participation in more than 1,500 clinical trials in the past 5 years. Partner with us to unlock your next cell therapy innovation.

Antibody-drug conjugates (ADCs) solutions

ADC development made easier than ever

Leverage our deep scientific expertise for seamless antibody-drug conjugate (ADC) development. Our dedicated MDs and PhDs provide expert guidance tailored to your research and business needs and help you achieve critical milestones faster.

Biomarker solutions

Propel your drug development with groundbreaking biomarker insights

Recent advances have shifted the focus from traditional therapies to precision medicine, driven by the strategic use of biomarkers. These essential tools accelerate the discovery, development, and approval of new drugs, enabling faster delivery of more innovative treatments while adding significant value to development programs. Our specialized team enables pharmaceutical partners with actionable insights to drive informed decisions and accelerate biomarker development.

Introducing RaDaR® ST for Pharma Partners

Real-time molecular insights
RaDaR ST provides tumor-informed MRD detection, identifying residual ctDNA with confidence. MRD tests can help biopharma companies optimize clinical trial design by enriching trial populations, following response to treatment, and as a surrogate endpoint for clinical trials.

PanTracer™ Tissue and PanTracer™ LBx

Unlock the complexities of every tumor
Clinically and analytically validated Comprehensive Genomic Profiling (CGP) assays across both tissue and liquid biopsy, providing biopharma partners with actionable genomic insights to confidently advance precision oncology development.

Introducing Paletrra™ -where insight ignites innovation

Paletrra is a comprehensive, end-to-end, AI-driven spatial proteomics solution that transforms your precious tissue into deep visual insights - empowering confident decisions and accelerating therapeutic advancement. Paletrra’s whole-tissue workflow, AI-driven image analysis, and advanced spatial analytics unlocks salient biological insights. With both off-the-shelf test menu and customization option, Paletrra is delivered through high-touch collaboration backed by scientific expertise.

Three people looking at oncology data on a screen

Regulatory support

NeoGenomics delivers thoughtful oversight to ensure compliance with federal regulations for a successful commercial launch. We provide in-house regulatory and compliance support to our pharma and biotech partners to support their clinical trial requirements, and we have enjoyed a 100% success rate with institutional review board (IRB) and FDA submissions,* often receiving consistent favorable FDA feedback.

More info on regulatory support

*Data on file.

Companion diagnostics

The use of biological signatures to identify patients who are likely to benefit from a particular therapy has greatly accelerated the pace of drug development and approval. Simultaneously, it has complicated drug development by requiring the co-development of a companion diagnostic (CDx) assay to accurately and reproducibly select patients who are likely to benefit from said therapy. We provide specialized scientific expertise to ensure CDx success and accelerate your pipeline progress.

Commercialization support

We are pleased to offer complete end-to-end support throughout the commercialization process. NeoGenomics is one of the largest oncology-focused laboratories in the United States, with established relationships with major in vitro diagnostic (IVD) providers, single-site FDA-approved test approvals, and partnerships for ex-US launch needs.

Oncology data solutions

Our commitment to advancing cancer care with real-world multi-modal oncology data solutions makes us a valuable partner to pharmaceutical companies.

Understanding the vital role that data play in precision oncology, NeoGenomics has the scientific expertise and innovation to help pharma companies succeed sooner.

Partner testimonials

Partnering with Neogenomics has been a positive experience for my studies in terms of ease of contracting, robust data generation, flexible data transfer options, close collaboration on troubleshooting, great communication for company and study level changes and support. My projects with Neogenomics are top of list across the board.

— Top 20 pharmaceutical organization

Wide range of assay platforms and customizability. Great support from biz dev and PM teams.

— Small biotechnology organization

We have worked very closely on many studies with NeoGenomics, including studies that required a CDx approval. They are a trusted testing laboratory for us.

— Top 20 pharmaceutical organization

The Neogenomics team is easy to work with, the lab is consistent on providing timely and correct results, and the PM team provides prompt communication.

— Small biotechnology organization

The NeoGenomics team is up to date with the latest scientific advances and is proactive when it comes to project management.

— Top 20 pharmaceutical organization

The program was well set up and run and the results were ahead of schedule.

— Small biotechnology organization

Check out our latest precision medicine resources

Use the form below to access our full library of white papers, on demand webinars and case studies. We invite you to check on this library often for newly added content.

Scientific publications

Review our variety of publications and poster presentations.

Become a NeoGenomics partner

Join the growing list of renowned pharma companies who have developed winning partnerships with NeoGenomics to advance their research and business needs. Contact us to learn more.